A detailed history of Signaturefd, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 8,107 shares of SRPT stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,107
Previous 10,751 24.59%
Holding current value
$1.01 Million
Previous $1.7 Million 40.4%
% of portfolio
0.02%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$124.33 - $156.75 $328,728 - $414,447
-2,644 Reduced 24.59%
8,107 $1.01 Million
Q2 2024

Jul 29, 2024

BUY
$113.33 - $163.85 $1.13 Million - $1.63 Million
9,942 Added 1228.92%
10,751 $1.7 Million
Q1 2024

May 03, 2024

BUY
$93.7 - $141.53 $24,549 - $37,080
262 Added 47.9%
809 $104,000
Q4 2023

Jan 31, 2024

SELL
$67.31 - $124.76 $2,423 - $4,491
-36 Reduced 6.17%
547 $52,000
Q3 2023

Nov 03, 2023

BUY
$102.5 - $123.59 $10,352 - $12,482
101 Added 20.95%
583 $70,000
Q2 2023

Aug 01, 2023

BUY
$106.4 - $157.19 $4,362 - $6,444
41 Added 9.3%
482 $55,000
Q1 2023

Apr 28, 2023

BUY
$117.53 - $155.99 $6,699 - $8,891
57 Added 14.84%
441 $60,000
Q4 2022

Jan 27, 2023

BUY
$100.86 - $132.13 $806 - $1,057
8 Added 2.13%
384 $49,000
Q3 2022

Nov 08, 2022

BUY
$75.71 - $119.24 $529 - $834
7 Added 1.9%
376 $42,000
Q2 2022

Aug 10, 2022

SELL
$62.69 - $88.44 $250 - $353
-4 Reduced 1.07%
369 $28,000
Q1 2022

May 02, 2022

SELL
$63.15 - $90.42 $19,450 - $27,849
-308 Reduced 45.23%
373 $29,000
Q4 2021

Jan 25, 2022

SELL
$77.28 - $99.42 $4,945 - $6,362
-64 Reduced 8.59%
681 $61,000
Q3 2021

Oct 28, 2021

BUY
$65.97 - $92.48 $5,409 - $7,583
82 Added 12.37%
745 $69,000
Q2 2021

Jul 26, 2021

BUY
$69.38 - $86.75 $26,572 - $33,225
383 Added 136.79%
663 $52,000
Q1 2021

Apr 30, 2021

BUY
$72.25 - $168.95 $17,123 - $40,041
237 Added 551.16%
280 $21,000
Q4 2020

Feb 11, 2021

BUY
$125.56 - $178.74 $502 - $714
4 Added 10.26%
43 $7,000
Q3 2020

Nov 03, 2020

BUY
$127.12 - $172.34 $1,398 - $1,895
11 Added 39.29%
39 $5,000
Q2 2020

Jul 30, 2020

BUY
$93.0 - $171.7 $1,860 - $3,434
20 Added 250.0%
28 $4,000
Q1 2020

Apr 23, 2020

BUY
$82.38 - $131.64 $82 - $131
1 Added 14.29%
8 $1,000
Q3 2019

Oct 16, 2019

BUY
$72.81 - $156.91 $436 - $941
6 Added 600.0%
7 $1,000
Q2 2019

Jul 31, 2019

BUY
$112.21 - $151.95 $112 - $151
1 New
1 $0

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.